glp 1 heart rate Retatrutide rate: what the clinical data actually shows Heart rate lowered, post GLP-1

Evaluating Biometric Trend Drivers: How to reflect medical breakthroughs and other drivers in forward-looking assumptions explores the practicalities of how to maintain an up-to-date view on emerging drivers such as AOMs and provides a framework for incorporating insured impacts into insured improvement bases

V., & Elisaf, M

J Cancer Res Clin Oncol 151: 103, 2025

Asthma Asthma is classified as a widespread chronic inflammatory malady, affecting an estimated 4% of the global population [242]

In a clinical trial involving individuals with established cardiovascular disease, retatrutide reduced the risk of major adverse cardiovascular events, such as heart attacks, strokes, and cardiovascular death